Hoyos, Camilla M.
Gordon, Christopher
Terpening, Zoe
Norrie, Louisa
Lewis, Simon J. G.
Hickie, Ian B.
Naismith, Sharon L.
Funding for this research was provided by:
NHMRC (632689)
Article History
Received: 26 August 2019
Accepted: 16 April 2020
First Online: 29 April 2020
Ethics approval and consent to participate
: This research was approved by the Human Research Ethics Committee of The University of Sydney and was conducted in accordance with the latest version of the Declaration of Helsinki. Written informed consent was obtained from all participants.
: No individual participant data or any identifiable data is being published so no specific consent has been given. Participants were informed in the information statement that the de-identifiable data would be published.
: Dr. Hoyos, A/Prof Gordon, Prof Lewis, Dr. Norrie, Dr. Terpening and Prof Naismith have no conflicts to declare. Professor Ian Hickie was an inaugural Commissioner on Australia’s National Mental Health Commission (2012–18). He is the Co-Director, Health and Policy at the Brain and Mind Centre (BMC) University of Sydney. The BMC operates an early-intervention youth services at Camperdown under contract to headspace. Professor Hickie has previously led community-based and pharmaceutical industry-supported (Wyeth, Eli Lily, Servier, Pfizer, AstraZeneca) projects focused on the identification and better management of anxiety and depression. He was a member of the Medical Advisory Panel for Medibank Private until October 2017, a Board Member of Psychosis Australia Trust and a member of Veterans Mental Health Clinical Reference group. He is the Chief Scientific Advisor to, and an equity shareholder in, Innowell. Innowell has been formed by the University of Sydney and PwC to deliver the $30 m Australian Government-funded ‘Project Synergy’. Project Synergy is a 3 year program for the transformation of mental health services through the use of innovative technologies.